Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.
Rheumatoid arthritis (RA) associates with excess cardiovascular (CV) morbidity and mortality. New screening tools are needed to better identify patients at increased CV risk. Microalbuminuria (MA) has been shown to associate with inflammation and future cardiovascular disease (CVD). In the present study, we assessed the prevalence of MA in a secondary care cohort of RA patients, aimed to identify factors associated with its presence and addressed its relationship to CVD and the metabolic syndrome (MetS). A total of 342 RA patients were studied. MA was defined as an albumin-creatinine ratio ≥22 (males) or ≥31 (females) milligrams per gram creatinine. The independence of the associations of MA was evaluated using binary logistic regression analysis. Prevalence of MA was 11.9%. Subjects with MA had increased prevalence of hypertension (HT), insulin resistance and type 2 diabetes. In binary logistic regression, only HT (OR = 5.22, 95%CI: 1.51-18.07, p = 0.009) was significantly associated with MA. There was no association between prevalent CVD and MA, but patients with MA had twofold increased odds of having the MetS. MA is relatively common in RA patients and is independently associated with the presence of HT. Given the association of MA with MetS, future prospective studies are needed to establish the use of MA as a screening tool for RA patients at increased CVD risk.
Daoussis
Dimitrios
D
Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, DY1 2HQ, UK.
Panoulas
Vasileios F
VF
John
Holly
H
Toms
Tracey E
TE
Antonopoulos
Ioannis
I
Treharne
Gareth
G
Nightingale
Peter
P
Douglas
Karen M J
KM
Kitas
George D
GD
D000368:Aged; D000419:Albuminuria / Q000150:complications* / Q000453:epidemiology; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000150:complications / Q000453:epidemiology; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005260:Female; D017612:Gold Compounds / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000453:epidemiology; D007249:Inflammation / Q000150:complications / Q000453:epidemiology; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000453:epidemiology; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use*; D015995:Prevalence; D012307:Risk Factors
D018501:Antirheumatic Agents; D015415:Biomarkers; D017612:Gold Compounds; D010396:Penicillamine
Diabetes Care. 2007 Jan;30(1):8-13
17192325
Circulation. 2005 Mar 22;111(11):1370-6
15738353
Arch Intern Med. 1971 Dec;128(6):961-4
5132456
Clin Sci (Lond). 1999 Jul;97(1):37-43
10369792
Kidney Int. 2000 Oct;58(4):1703-10
11012904
Atherosclerosis. 2001 Jul;157(1):197-202
11427221
Circulation. 2002 Oct 1;106(14):1777-82
12356629
Arthritis Res Ther. 2008;10(6):R145
19091101
Diabetes. 1998 May;47(5):793-800
9588452
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
Ann Rheum Dis. 2010 Mar;69(3):517-21
19279016
J Am Soc Nephrol. 2003 Feb;14(2):469-77
12538749
Diabetologia. 1985 Jul;28(7):412-9
3899825
Lancet. 1994 Jul 2;344(8914):14-8
7912295
JAMA. 2001 Jul 25;286(4):421-6
11466120
Nephron Clin Pract. 2004;96(4):c107-14
15122064
Curr Opin Cardiol. 2006 Jan;21(1):1-6
16355022
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1702-8
19608975
Intern Med. 2007;46(7):341-6
17409594
Kidney Int. 2003 Feb;63(2):624-33
12631127
Vasc Med. 2001 Nov;6(4):257-64
11958393
Arthritis Res Ther. 2009;11(4):R116
19630964
J Intern Med. 1995 Feb;237(2):195-203
7852923
Ann Intern Med. 1999 Mar 16;130(6):461-70
10075613
Hypertension. 1997 Nov;30(5):1135-43
9369267
Rheumatology (Oxford). 2003 May;42(5):607-13
12709534
JAMA. 2003 Dec 10;290(22):2945-51
14665655
Rheumatology (Oxford). 2008 Jan;47(1):72-5
18077493
Lancet. 1974 Jun 15;1(7868):1190-2
4134681
N Engl J Med. 1984 Feb 9;310(6):356-60
6690964
Rheumatology (Oxford). 2007 Sep;46(9):1466-70
17644822
Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2414-9
15486313
Circulation. 2004 Sep 7;110(10):1251-7
15326061
Ann Rheum Dis. 2006 Mar;65(3):348-53
16079169
J Intern Med. 2001 Jun;249(6):519-26
11422658
Atherosclerosis. 2008 Feb;196(2):756-63
17266963
Rheumatology (Oxford). 2004 Apr;43(4):537-8; author reply 538
15024150
Lancet. 1988 Sep 3;2(8610):530-3
2900920
Am J Cardiol. 2004 Dec 15;94(12):1554-8
15589016
Arthritis Rheum. 1995 Jan;38(1):44-8
7818570
J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
10902785
Ann Rheum Dis. 1995 Mar;54(3):189-92
7748016
J Hypertens. 2007 Sep;25(9):1751-62
17762635
Rheumatology (Oxford). 2007 Sep;46(9):1477-82
17704521
Arthritis Res Ther. 2009;11(4):R110
19607680
Br J Rheumatol. 1986 May;25(2):206-9
3708236